NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

The new Center for Recovery and Wellbeing and a Pathways to Recovery website seeks to break down barriers for those fighting addiction.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open ...

More than 60 pharmacies have allegedly offered incentives to encourage doctors and patients to use their services to maximize ...

Reducing cravings is important because it lowers the likelihood of relapse and helps people stay committed to their recovery ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...